More convenient format for media fill broth

Published: 23-Jun-2010
Design & Build Manufacturing Ingredients Packaging Regulatory

Animal-free media fill broth is now available in ready-to-use bags

Provider of microbiology supplies, Oxoid now offers Cold Filterable Vegetable Peptone Broth (cfVPB) in ready-prepared in low-density Bioprocess Containers (BPCs). Designed specifically for pharmaceutical media fill trials, these ready-to-use bags can simply be connected to customers’ process simulation, eliminating the need for bulk media preparation.

The BPCs are manufactured from a medical grade plastic film that meets USP Class VI requirements and are certified free from animal-derived components. Connection is made through a male or female connector that is attached to the BPC with C-Flex tubing.

Oxoid cfVPB is also certified free from animal-derived components, making it ideal for production environments in the pharmaceutical industry, where there is a need to control the risk of contamination from animal-derived materials–particularly with the emergence of diseases such as transmissible spongiform encephalopathies (TSE).

‘BPC’s provide an efficient means for companies to save time and resources,’ said Maria Higgins, pharmaceutical applications manager, Oxoid products. ‘The containers reduce waste and lower cleaning costs. Moreover, the BPCs minimise the risk of cross-contamination, allowing companies to meet regulatory standards.’ says the company.

The cfVPB is gamma-irradiated at a dose validated to be lethal for all yeasts, moulds and bacteria, including bacterial spores and mycoplasmas. The BPCs are, likewise, gamma-irradiated. The medium is prepared using water-for-injection–quality water. The BPCs are aseptically filled, ensuring that the prepared medium is suitable for use in pharmaceutical clean room support areas. The product is also accompanied with quality certification providing full traceability for each batch.

The broth is available as standard in 10 and 20 litre volume BPCs; other sizes are custom-made.
See more

You may also like

Regulatory

Novo Nordisk wins positive ruling for semaglutide compound patent from China’s Supreme People’s Court

Read more
The company has welcomed a decision by China’s Supreme People’s Court affirming the validity of its semaglutide compound patent, strengthening confidence for foreign drugmakers operating in the Chinese market

Trending Articles

  1. Grifols receives US FDA approval for new fibrinogen concentrate: FESILTY (fibrinogen, human-chmt) The fibrinogen concentrate complements Grifols’ bleeding management portfolio, expanding therapeutic options for patients
  2. ten23 health QC lab to support commercial product testing for US customer following FDA approvals This pivotal regulatory milestone enables FDA-compliant release and stability testing for injectable drug products throughout the clinical and commercial phases, in addition to manufacturing the commercial product
  3. From data to decisions: applying criticality and failure probability in process risk mitigation This article presents an exploration of how structured, data-based methods enhance quality control, optimise specifications and improve process robustness throughout the product lifecycle
  4. When science meets security: the future of small molecule outsourcing Looking across 2025 and into 2026, chemical and pharmaceutical manufacturing is navigating a period of rapid transition, with trends emerging that will influence competitiveness for years to come
  5. Hansa Biopharma submits BLA to FDA for Imlifidase in desensitisation for kidney transplantation Imlifidase is an enzyme that rapidly and efficiently cleaves all types of immunoglobulin G (IgG) antibodies both intra- and extra-vascularly to inhibit IgG-mediated immune response

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Regulatory

Novo Nordisk wins positive ruling for semaglutide compound patent from China’s Supreme People’s Court

The company has welcomed a decision by China’s Supreme People’s Court affirming the validity of its semaglutide compound patent, strengthening confidence for foreign drugmakers operating in the Chinese market
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Redefining tablet coatings: beyond aesthetics to functionality and sustainability

By investing in innovative coating technologies today, the pharmaceutical and nutraceutical industries can ensure resilience and relevance in an increasingly complex landscape
Manufacturing

When science meets security: the future of small molecule outsourcing

Looking across 2025 and into 2026, chemical and pharmaceutical manufacturing is navigating a period of rapid transition, with trends emerging that will influence competitiveness for years to come
Regulatory

Grifols receives US FDA approval for new fibrinogen concentrate: FESILTY (fibrinogen, human-chmt)

The fibrinogen concentrate complements Grifols’ bleeding management portfolio, expanding therapeutic options for patients
Regulatory

Hansa Biopharma submits BLA to FDA for Imlifidase in desensitisation for kidney transplantation

Imlifidase is an enzyme that rapidly and efficiently cleaves all types of immunoglobulin G (IgG) antibodies both intra- and extra-vascularly to inhibit IgG-mediated immune response
Manufacturing

The story of an East-West German company | 150 years of Romaco Kilian

Kilian’s story tells of the rise, fall and resurgence of a Berlin company steeped in tradition, which is now based in Cologne. It is the story of the entrepreneur Fritz Kilian, who turned a small locksmith’s workshop in Berlin into a successful company that is still a leading manufacturer of tablet presses today. It is the story of a visionary whose legacy has endured the test of time and continues to this day
Manufacturing

Dual stage degasser vacuum pump from Biotech Fluidics

Biotech Fluidics has introduced a durable dual stage moulded vacuum pump designed to improve your fluidic degassing experience
Subscribe now